MENU
+Compare
FDMT
Stock ticker: NASDAQ
AS OF
Jan 14, 04:59 PM (EDT)
Price
$8.76
Change
+$0.90 (+11.45%)
Capitalization
449.08M

FDMT 4D Molecular Therapeutics Forecast, Technical & Fundamental Analysis

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more

FDMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for FDMT with price predictions
Jan 13, 2026

FDMT in downward trend: price dove below 50-day moving average on December 17, 2025

FDMT moved below its 50-day moving average on December 17, 2025 date and that indicates a change from an upward trend to a downward trend. In of 25 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for FDMT crossed bearishly below the 50-day moving average on December 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FDMT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FDMT entered a downward trend on January 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FDMT's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where FDMT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 13, 2026. You may want to consider a long position or call options on FDMT as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FDMT just turned positive on January 13, 2026. Looking at past instances where FDMT's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

FDMT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FDMT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.217) is normal, around the industry mean (30.106). P/E Ratio (0.000) is within average values for comparable stocks, (51.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.888). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. FDMT's P/S Ratio (3333.333) is very high in comparison to the industry average of (322.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FDMT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
FDMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

FDMT is expected to report earnings to fall 47.33% to -53 cents per share on February 27

4D Molecular Therapeutics FDMT Stock Earnings Reports
Q4'25
Est.
$-0.53
Q3'25
Est.
$-1.01
Q2'25
Missed
by $0.25
Q1'25
Est.
$-0.86
Q4'24
Missed
by $0.05
The last earnings report on November 10 showed earnings per share of -100 cents, meeting the estimate of -100 cents. With 539.52K shares outstanding, the current market capitalization sits at 449.08M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VNVCX15.990.11
+0.69%
Natixis Vaughan Nelson Mid Cap C
SELCX41.91-0.02
-0.05%
SEI Large Cap Growth F (SIMT)
MIPIX18.11-0.07
-0.39%
Matthews Asia Dividend Instl
LRAGX18.07-0.10
-0.55%
Lord Abbett International Growth R3
RREMX17.82-0.10
-0.56%
RBC Emerging Markets Equity R6

FDMT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+4.80%
RGNX - FDMT
47%
Loosely correlated
-0.20%
CLDX - FDMT
46%
Loosely correlated
+1.01%
KURA - FDMT
43%
Loosely correlated
+0.44%
TNGX - FDMT
43%
Loosely correlated
-2.06%
IDYA - FDMT
43%
Loosely correlated
-4.75%
More